Abstract: Methods of inhibiting metastasis or maintenance of various cancers are provided. In particular, the method makes use of fact that certain trafficking of cancers depend upon identified proteins, which serve as markers. Additional methods of screening are also provided.
Abstract: Covalent HCV NS4A-NS3 complexes comprising the central hydrophobic domain of native HCV NS4A peptide, a linker, and the HCV NS3 serine protease domain, wherein the hydrophobic domain of native HCV NS4A peptide is tethered by the linker to the amino terminus of the HCV NS3 protease domain.
Type:
Grant
Filed:
October 6, 2000
Date of Patent:
November 25, 2003
Assignee:
Schering Corporation
Inventors:
Bruce A. Malcolm, S. Shane Taremi, Patricia C. Weber, Nanhua Yao
Abstract: The present invention relates to compositions and crystals of farnesyl protein transferase and farnesyl protein transferase in complex with substrates and inhibitors. Also disclosed are crystallization conditions for these compositions and their use for structural determination of FPT:FPP/FPP analog:peptide/inhibitor complexes.
Type:
Grant
Filed:
July 29, 1999
Date of Patent:
March 25, 2003
Assignee:
Schering Corporation
Inventors:
Corey Strickland, Zhen Wu, William T. Windsor, Patricia C. Weber
Abstract: The present invention relates to crystalline compositions comprising farnesyl protein transferase-like polypeptides in complex with substrates and inhibitors. Also disclosed are crystallization conditions for these compositions and their use for structural determination of FPT:FPP/FPP analog: peptide/inhibitor complexes.